Organic cation transporters in health and disease
H Koepsell, LC Daws - Pharmacological reviews, 2020 - Elsevier
The organic cation transporters (OCTs) OCT1, OCT2, OCT3, novel OCT (OCTN) 1, OCTN2,
multidrug and toxin exclusion (MATE) 1, and MATE kidney-specific 2 are polyspecific …
multidrug and toxin exclusion (MATE) 1, and MATE kidney-specific 2 are polyspecific …
Metformin use in pregnancy: promises and uncertainties
RS Lindsay, MR Loeken - Diabetologia, 2017 - Springer
Metformin has been prescribed in pregnancy for over 40 years; for much of this time, use has
been limited both in numbers and geographically, and the evidence base has been confined …
been limited both in numbers and geographically, and the evidence base has been confined …
Placental transporter localization and expression in the human: the importance of species, sex, and gestational age differences
N Walker, P Filis, U Soffientini… - Biology of …, 2017 - academic.oup.com
The placenta is a critical organ during pregnancy, essential for the provision of an optimal
intrauterine environment, with fetal survival, growth, and development relying on correct …
intrauterine environment, with fetal survival, growth, and development relying on correct …
Position paper of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), and the Italian Study Group of Diabetes in pregnancy …
L Sciacca, C Bianchi, S Burlina, G Formoso… - Acta Diabetologica, 2023 - Springer
Objective This document purpose is to create an evidence-based position statement on the
role of metformin therapy in pregnancy complicated by obesity, gestational diabetes (GDM) …
role of metformin therapy in pregnancy complicated by obesity, gestational diabetes (GDM) …
Metformin in pregnancy: mechanisms and clinical applications
S Hyer, J Balani, H Shehata - International journal of molecular sciences, 2018 - mdpi.com
Metformin use in pregnancy is increasing worldwide as randomised controlled trial (RCT)
evidence is emerging demonstrating its safety and efficacy. The Metformin in Gestational …
evidence is emerging demonstrating its safety and efficacy. The Metformin in Gestational …
Role of solute carriers in response to anticancer drugs
Q Li, Y Shu - Molecular and cellular therapies, 2014 - Springer
Membrane transporters play critical roles in moving a variety of anticancer drugs across
cancer cell membrane, thereby determining chemotherapy efficacy and/or toxicity. The …
cancer cell membrane, thereby determining chemotherapy efficacy and/or toxicity. The …
Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia
X Huang, P Anderle, L Hostettler, MU Baumann… - BMC genomics, 2018 - Springer
Background Gestational disorders such as intrauterine growth restriction (IUGR) and pre-
eclampsia (PE) are main causes of poor perinatal outcomes worldwide. Both diseases are …
eclampsia (PE) are main causes of poor perinatal outcomes worldwide. Both diseases are …
Placental control of drug delivery
The placenta serves as the interface between the maternal and fetal circulations and
regulates the transfer of oxygen, nutrients, and waste products. When exogenous …
regulates the transfer of oxygen, nutrients, and waste products. When exogenous …
Pathway of maternal serotonin to the human embryo and fetus
HJ Kliman, SB Quaratella, AC Setaro… - …, 2018 - academic.oup.com
Abstract Serotonin [5-hydroxytryptamine (5-HT)] is essential to intrauterine development, but
its source is debated. We used immunocytochemistry to gauge 5-HT, its biosynthetic enzyme …
its source is debated. We used immunocytochemistry to gauge 5-HT, its biosynthetic enzyme …
Drug transporters expressed in the human placenta and models for studying maternal‐fetal drug transfer
Tremendous efforts have been directed to investigate the ontogeny of drug transporters in
fetuses, neonates, infants, and children based on their importance for understanding drug …
fetuses, neonates, infants, and children based on their importance for understanding drug …